» Articles » PMID: 11117546

Neurological Disability Correlates with Spinal Cord Axonal Loss and Reduced N-acetyl Aspartate in Chronic Multiple Sclerosis Patients

Overview
Journal Ann Neurol
Specialty Neurology
Date 2000 Dec 16
PMID 11117546
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

Axonal degeneration has been proposed as a cause of irreversible neurological disability in multiple sclerosis (MS) patients. The purpose of this study was to quantify axonal loss in spinal cord lesions from 5 paralyzed (Expanded Disability Status Scale score > or =7.5) MS patients and to determine if axonal number or volume correlated with levels of the neuronal marker N-acetyl aspartate (NAA). Axonal loss in MS lesions ranged from 45 to 84% and averaged 68%. NAA levels were significantly reduced (>50%) in cross sections of spinal cords containing MS lesions. Reduced NAA correlated with reduced axonal numbers within lesion areas. In addition, NAA levels per axonal volume were significantly reduced in demyelinated axons (42%) and in myelinated axons in normal-appearing white matter (30%). The data support axonal loss as a major cause of irreversible neurological disability in paralyzed MS patients and indicate that reduced NAA as measured by magnetic resonance spectroscopy can reflect axonal loss and reduced NAA levels in demyelinated and myelinated axons.

Citing Articles

Selective retinoid X receptor agonism promotes functional recovery and myelin repair in experimental autoimmune encephalomyelitis.

Kasheke G, Hendy B, Dorighello G, Uccelli N, Gothie J, Novorolsky R Acta Neuropathol Commun. 2024; 12(1):197.

PMID: 39707547 PMC: 11662761. DOI: 10.1186/s40478-024-01904-x.


Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.

Perdaens O, van Pesch V Int J Mol Sci. 2024; 25(23.

PMID: 39684351 PMC: 11641818. DOI: 10.3390/ijms252312637.


High Blood Pressure and Impaired Brain Health: Investigating the Neuroprotective Potential of Magnesium.

Alateeq K, Walsh E, Cherbuin N Int J Mol Sci. 2024; 25(22).

PMID: 39595928 PMC: 11594239. DOI: 10.3390/ijms252211859.


Microstructural Damage and Repair in the Spinal Cord of Patients With Early Multiple Sclerosis and Association With Disability at 5 Years.

Gaubert M, Combes B, Bannier E, Masson A, Caron V, Baudron G Neurol Neuroimmunol Neuroinflamm. 2024; 12(1):e200333.

PMID: 39571137 PMC: 11587990. DOI: 10.1212/NXI.0000000000200333.


Autoimmune diseases refractory to corticosteroids and immunosuppressants.

Elkoshi Z Front Immunol. 2024; 15:1447337.

PMID: 39351223 PMC: 11439723. DOI: 10.3389/fimmu.2024.1447337.